Log In
Print
BCIQ
Print
Print this Print this
 

BNC101 (formerly ET-101)

  Manage Alerts
Collapse Summary General Information
Company Bionomics Ltd.
DescriptionHumanized mAb targeting leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5; GPR49)
Molecular Target Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) (GPR49)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation

Partner

Lonza Group Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today